8.9% of patients on combo had little to no cancer at surgery vs 1% on hormone therapy alone Treatment regimen cut disease recurrence or death risk by 20% Researchers call data 'paradigm changing' J&J ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We conducted a ...

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the ...

A previous trial involving patients with metastatic prostate cancer that was resistant to androgen pathway modulation (formerly referred to as castration-resistant) showed that adding talazoparib ...

It's not an easy conversation for men to have, but talking about prostate problems is important. Common symptoms include urinary frequency or urgency or difficulty going to the bathroom. For years, ...

Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine ...

Among men with high-risk localized prostate cancer, those receiving neoadjuvant apalutamide combination therapy had improved potency recovery by 12 months and reduced rates of positive margins ...

Pae is a General Partner at SOSV and CTO at IndieBio, where she is responsible for portfolio management and technical oversight. Prior to joining IndieBio, Pae served as the Scientific Director of ...

Both robot-assisted simple prostatectomy (RASP) and laser enucleation of the prostate (LEP) are safe and effective surgical options for large-volume benign prostatic hyperplasia (BPH), according to a ...